Effects of Shao Pai febrile diseases nursing in patients with COPD of lung and kidney deficiency type
10.3760/cma.j.cn115682-20210307-01003
- VernacularTitle:绍派伤寒调护法在肺肾气虚型慢性阻塞性肺疾病患者中的应用
- Author:
Fufang CHEN
1
;
Guomiao SHEN
;
Feiqin ZHU
Author Information
1. 绍兴市中医院呼吸内科，绍兴 312000
- Keywords:
Pulmonary disease, chronic obstructive;
Quality of life;
Shao Pai febrile diseases nursing;
Lung function;
Dyspnea
- From:
Chinese Journal of Modern Nursing
2022;28(4):511-515
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To explore effect of Shao Pai febrile diseases nursing in patients with chronic obstructive pulmonary disease (COPD) of lung and kidney deficiency type.Methods:From January 2019 to August 2020, convenience sampling was used to select 100 patients with COPD of lung and kidney deficiency type in the Respiratory Department, Shaoxing Hospital of Traditional Chinese Medicine as the research object. According to the random number table method, the patients were divided into the nursing group and the control group, 50 cases in each group. The control group was intervened by conventional nursing, while the nursing group conducted Shao Pai febrile diseases nursing on the basis of conventional nursing, and the intervention was continued for three months. The modified Medical Research Council (mMRC) and St George's Respiratory Questionnaire (SGRQ) were used to evaluate the influence of dyspnea on quality of life. The forced expiratory volume in one second (FEV1) , FEV1 as a percentage of predicted force vital capacity (FEV1%) , and peak expiratory flow (PEF) were compared between the two groups before and after treatment.Results:After treatment, the dyspnea in the nursing group was better than that in the control group, and the total score of SGRQ and the scores of each dimension were lower than those in the control group, and the FEV1, FEV1% and PEF were higher than those in the control group, and the above differences were statistically significant ( P<0.05) . Conclusions:The Shao Pai febrile diseases nursing can further improve the lung function of patients with COPD of lung and kidney deficiency type, reduce the degree of dyspnea, and improve the quality of life of the patients.
